Opening book details…
About this book
In vivo dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the Acinetobacter baumannii-calcoaceticus complex by John O'Donnell & Angela Tanudra & April Chen & Joseph Newman & Sarah M. McLeod & Rubén Tommasi is a book available to read on EtoBox.
- Author
- John O'Donnell & Angela Tanudra & April Chen & Joseph Newman & Sarah M. McLeod & Rubén Tommasi
- Publisher
- American Society for Microbiology
- Published
- 2023
- Language
- EN
More by John O'Donnell & Angela Tanudra & April Chen & Joseph Newman & Sarah M. McLeod & Rubén Tommasi
Similar books
- In vitro pharmacokinetics/pharmacodynamics of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against Acinetobacter baumannii-calcoaceticus complex — John O'Donnell & Angela Tanudra & April Chen & Alita A. Miller & Sarah M. McLeod & Rubén Tommasi (2023)
- In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021 — James A. Karlowsky & Meredith A. Hackel & Sarah M. McLeod & Alita A. Miller (2022)
- Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii — Magdalena Zalacain & Pauline Achard & Agustina Llanos & Ian Morrissey & Stephen Hawser & Kirsty Holden & Eleanor Toomey & David Davies & Simon Leiris & Carole Sable & Adeline Ledoux & Justine Bousquet & Jérôme Castandet & Clarisse Lozano & Martin... (2024)
- Characterization of Acinetobacter Baumannii-calcoaceticus Complex Isolates and Microbiological Outcome for Patients Treated with Sulbactam-durlobactam in a Phase 3 Trial (ATTACK) — Alita A. Miller & Samir H. Moussa & Sarah M. McLeod (2024)
- Activity of Ampicillin-sulbactam, Sulbactam-durlobactam, and Comparators Against Acinetobacter Baumannii-calcoaceticus Complex Strains Isolated from Respiratory and Bloodstream Sources: Results from ACNBio Study — Ecem Buyukyanbolu & Jill Argotsinger & Eric T. Beck & Robin R. Chamberland & Andrew E. Clark & Anne R. Daniels & Rachael Liesman & Mark Fisher & Philip Gialanella & Jonathan Hand & Amanda T. Harrington & Romney M. Humphries & Holly Huse & Robert... (2025)
- Comparative Effectiveness and Safety of Colistin-based Versus High-dose Ampicillin/sulbactam-based Combination Therapy for Nosocomial Pneumonia Caused by Carbapenem-resistant Acinetobacter Baumannii — Jaehoon Lee & Imchang Lee & Ki-Byung Lee & Seung Soon Lee (2025)